《Jpad-journal Of Prevention Of Alzheimers Disease》雜志的最新年發(fā)文量為108篇。
這表明該刊在每年都會精選并發(fā)表一定數(shù)量的高質(zhì)量文章，以保持其在臨床神經(jīng)病學(xué)領(lǐng)域的學(xué)術(shù)影響力。
該刊聚焦于醫(yī)學(xué)-臨床神經(jīng)病學(xué)領(lǐng)域的前沿研究，致力于推動該領(lǐng)域新技術(shù)和新知識的傳播與應(yīng)用。同時它積極鼓勵研究人員詳細發(fā)表其高質(zhì)量的實驗研究和理論成果。
該刊的平均審稿周期約為 。
Jpad-journal Of Prevention Of Alzheimers Disease 雜志發(fā)文統(tǒng)計
文章名稱引用次數(shù)
- Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research20
- Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's Disease16
- AADvac an Active Immunotherapy for Alzheimer's Disease and Non Alzheimer Tauopathies: An Overview of Preclinical and Clinical Development14
- Female Sex and Alzheimer's Risk: The Menopause Connection14
- Anti-Tau Trials for Alzheimer's Disease: A Report from the EU/US/CTAD Task Force13
- Increased Functional Connectivity After Listening to Favored Music in Adults With Alzheimer Dementia12
- Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force Report12
- Bifidobacterium Breve A1 Supplementation Improved Cognitive Decline in Older Adults with Mild Cognitive Impairment: An Open-Label, Single-Arm Study11
- Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force11
- Polygenic Risk Score Analysis of Alzheimer's Disease in Cases without APOE4 or APOE2 Alleles9
國家/地區(qū)發(fā)文量
- USA109
- France38
- England23
- Switzerland17
- Canada14
- GERMANY (FED REP GER)13
- Japan11
- Australia10
- Spain10
- Sweden10
